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Abstract
Early career academic cardiologists, whom many believe are an important component of the future 
of cardiovascular care, face a myriad of challenges. The Early Career Section Academic Working 
Group of the American College of Cardiology (ACC) along with senior leadership support, 
assessed the progress of this cohort from 2013–2016 with a global perspective. Data consisted of 
accessing National Heart Lung and Blood Institute (NHLBI) public information, American Heart 
Association and international organizations providing data, and a membership-wide survey. 
Although NHBLI increased funding of career development grants, only a small number of early 
career ACC members have benefited as funding of the entire cohort has decreased. Personal 
motivation, institutional support, and collaborators continued to be positive influential factors. 
Surprisingly, mentoring ceased to correlate positively with obtaining external grants. Totality of 
findings suggests that the status of early career academic cardiologists remain challenging; 
therefore, we recommend a set of attainable solutions.
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Background
Cardiovascular disease (CVD) is the number one cause of morbidity and mortality globally, 
and its incidence is rising at an alarming rate (1). In the United States (U.S.) alone, it is 
projected that by the year 2030, 45% of the population will have at least one CVD condition 
(2). Notably, after a long period of sustained decline in age adjusted CVD death rate (1950–
2014) (3), age adjusted death rates for heart disease and stroke in the US demonstrated 
statistically significant increases from 2014 to 2015 (4). To address this rising burden of 
cardiovascular disease, society relies on academic cardiologists in all settings to drive 
research (basic, translational, clinical, and population) and to train the next generation of 
cardiologists. Thus, it is critical to maintain and renew the pipeline of early career academic 
cardiologists (Table 1).
Early career academic cardiologists, defined as those within 10 years of completion of a 
cardiology fellowship, face enormous challenges. These challenges include limited funding, 
insufficient protected time, increased regulatory compliance burden, increased competition 
from pure Ph.D. scientists, and personal financial disincentives (5). This resulted in many 
cardiologists choosing to leave or never enter the academic workforce (5,6). As a response in 
2014, the Early Career Section Academic Working Group of the American College of 
Cardiology (ACC), along with senior leadership, published a manuscript based on status of 
the funding environment, and inputs from staff members of the National Heart Lung and 
Blood Institute (NHLBI) of the National Institutes of Health (NIH), and a survey of ACC 
early career academic cardiologists. The manuscript summarized challenges faced by these 
early academicians and proposed potential solutions that could be implemented by the ACC, 
academic institutions, and policy makers to address these challenges (5). So how far have we 
come in the past 3 years? To address this question, the Early Career Section Academic 
Working Group of the ACC continued collaboration with staff of NHLBI, re-surveyed early 
career academic cardiologists, and this time, included one of the fastest growing segment of 
the ACC – international cardiologists.(7) Furthermore, the American Heart Association 
(AHA) and international representation also have joined this effort to provide a global view 
of the state of early career academic cardiology.
The purpose of this 2017 update is to inform the cardiovascular community, academic 
leadership, and policy makers on the progress of early career academic cardiologists since 
the previous publication (5) and present potential solutions. We hope this manuscript will 
serve as a catalyst for discussion and policy changes that will promote the survival and 
success of early career academic cardiologists and the profession as a whole.
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METHODS
NHLBI personnel guided extraction of publicly accessible data. AHA provided their grant 
funding data. International representation (the German Center for Cardiovascular Research: 
Deutsches Zentrum für Herz-Kreislauf-Forschung – DZHK and ACC members working 
with their respective countries’ cardiology societies: Canada, India, Israel, Mexico) also 
provided data. Chief editors (Circulation and Journal of American College of Cardiology – 
Basic Translational Science) provided guidance. ACC conducted a membership-wide survey 
that was developed by the Academic Working Group of the Early Career Section of the 
ACC. Inclusion criteria consisted of self-identification as an academic cardiologist and ≤10 
years from completion of cardiology fellowship.
Statistical analysis of the responses was performed using SPSS version 23. Z-tests and t-tests 
were used to identify significant differences for categorical and continuous variables 
respectively. Pearson and Spearman correlation tests were used to evaluate the strength of 
relationships between continuous and rank variables respectively.
RESULTS
Responses, Motivations, and Tracks
Invitations to participate were emailed to 9646 early career members of the entire ACC in 
January and February of 2016. Of the 1131/9646 (12%) responses, 558/1131 (49%) were 
included in the study, 283/1131 (25%) branched out as pure clinicians, and 290/1131(26%) 
did not meet inclusion criteria Majority of the respondents practiced in the US (80%). 
International members reside and practice outside of the US. The distributions of 
professional roles (i.e., academic tracks in Table-1) remained similar between 2013 and 
2016 (Table 2). Thus, comparative analyses would not be confounded by different 
distribution of academic tracks (Figure 1).
Key motivations for early career members to pursue academic cardiology consist of 
academic environment, desire to do research, desire to teach, and interaction/exposure to 
diverse disciplines and new ideas (Figure-1B). A significant portion of all respondents 
(22%) dedicated ≥40% of their professional effort in research. International members 
differed from US members with a greater percentage engaged in research (Figure 1C), a 
lesser percentage in teaching (Figure 1C), a greater proportion participating in basic science 
research and single-institutional clinical trial, and a lesser proportion participating in 
retrospective database projects and quality improvement research (Figure 1D).
Research Funding
After years of declining funding, NIH/NHLBI increased funding of career development K-
grants from 2013 to 2015 (Figure 2). Mentored Clinical Scientist Development Award K-08 
(e.g., basic-translation science research) success rate increased from 26% in 2013 to 51% in 
2015. Mentored Patient-Oriented Research Career Development Award K-23 (e.g., clinical 
research) success rate increased from 30% in 2013 to 38% in 2015. In addition to funding 
more K-grants, NHLBI increased the amount of K-grant support from $500,000 to $625,000 
(not including indirect costs) and developed a new limited competition grant for K-grant 
Tong et al. Page 4
J Am Coll Cardiol. Author manuscript; available in PMC 2018 October 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
awardees to continue their development (RFA-HL-16-020)(8). NHLBI also increased 
funding rates of R01 grants from 14.1% in 2013 to 20.9% in 2016 (Online Figure 1). AHA 
fellow-to-faculty grants success rate declined (35% in 2013, 22% in 2016) and scientist 
development grant success rate slightly increased (16% in 2013, 19% in 2016); however, 
overall AHA grant success rates remained steady for last 10 years (Figure 2). Recently, ACC 
has established two new 1-year $70,000 grants (Keating and Presidential Awards) for early 
career investigators.
With increased NHLBI funding in mind, we then evaluated a group that could have 
benefited from these increases. This group consists of US members who reported >40% 
research effort. NIH has defined >40% research as a significant research commitment(8) and 
the >40% threshold would likely include members who are committed to pursue research 
but have not yet received a K-grant. Using >75% research effort would have biased the 
sampling to those who likely already achieved K-grant or K-grant equivalent funding 
(because >75% research effort is an NIH K-grant requirement); thus, >75% research effort 
was not chosen. Within this group, achieving NIH funding > $499K changed from 27% 
(10/37) in 2013 to 19% (16/85) in 2016, and achieving NIH funding >$1.2M changed from 
5.4%(2/37) in 2013 to 2.4% (2/85) in 2016 (Figure 2E). Thus, there were no increases in the 
combined NIH K-grant and R01-grant funding among early career ACC members despite 
the increased funding by the NHLBI.
To gain a global perspective, we then tallied total funding for all ACC members (Figure-2F). 
Despite the attempt to increase representation by including co-principal investigators and co-
investigators that were not counted in the 2013 study, the percentage of members who do not 
receive external grant support edged upward from 81% in 2013 to 83% in 2016. There was 
1% improvement for the $5K–$499K category. However, both top categories trended 
downward ($500K–$999K: 5% in 2013 to 4% in 2016; >$1M 3% in 2013 to 1% in 2016). 
Thus, external grant funding for the entire ACC early career population is likely to have 
decreased from 2013 to 2016 (Online Tables 1 and 2).
Matching publicly available NHLBI database of active K-grant awardees to the ACC 
database identified ACC early career academic cardiologists who successfully competed for 
NHLBI K-grants. Although the numbers are small, latest trends for ACC early career 
members achieving K-grants are encouraging (Figure 3). Among active K-grant awardees 
who achieved cardiovascular board certification, 25/90 (28%) are not members of the ACC.
We performed analyses by US states. The amount of fiscal year 2017 NIH research funding 
correlated with number of hospital beds and number of teaching hospitals (Figure 4A and 
B). Number of early career academic cardiologists (ECACs) also correlated with hospital 
beds and teaching hospitals (Figure 4C and D). However, ECAC funding did not correlate 
with amount of NIH research funding received by their state or number of teaching hospitals 
(Figure 4E and F).
Global Challenges
The vast majority (sum of top 2 affirmative response = 85% in Figure-5) of both US and 
international members believe that physicians should be a part of health care research, but 
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≥70% found lack of time as a challenge. Greater proportions of US members identified 
challenges of burdensome regulatory compliance, unstable external funding, and competing 
with pure PhDs. The use of clinical relative value units (RVU) without credit for research 
was also a greater challenge for U.S. members. While all members face challenges of home 
institutions not providing sufficient resources or funding, these challenges occur at greater 
proportions among international members (Figure 5).
International members face limited external research funding streams with limited funding 
amounts, lack of access to international cardiovascular registries, and lack of research 
collaborations. For example, despite an increase in clinical trials conducted at international 
sites (9), international members have limited participation in large international registries 
such as the National Cardiovascular Data Registry (NCDR) (10), which may limit 
opportunities for transnational research collaborations. Additionally, many international 
exchange programs are mostly focused on clinical experiences rather than research 
collaborations (7).
Only a minority of both international and US members reported satisfaction with support for 
educator development (Figure 5). The status of clinician-educator will be addressed in a 
separate manuscript.
Factors Leading to Achieving External Grant Support
We performed correlation analyses to identify which factors were associated with achieving 
increasing levels of funding (Table 4). Input variables consisted of factor rankings (Figure 5) 
and funding range bins ($0, $1–99K, $100K–249K, $250–499K, >$500K). Spearman 
correlation was used because of rank data and skewed funding distribution. Positive 
correlation consists of resultant r > 0.1 (|r| has values 0 to 1) that reached statistical 
significance. The US members’ analysis identified factors that correlated with achieving 
increasing NIH grant amounts. The all members’ analysis (including international members) 
identified factors that correlated with achieving grants from any source. Personal motivation, 
home institution (resources, value placed on academic pursuits), and connection to 
collaborators correlated to increasing levels of grant funding for all years and all groups. 
Home institution providing sufficient bridge funding continued to be a positive correlating 
factor for increasing NIH funding for U.S. members.
Surprisingly, mentoring ceased to be a positive correlating factor for grant funding in 2016 
(Table 4). We then performed a focused analysis on mentoring (Figure-6). Because US 
members with >40% research effort are positioned to apply for NIH K-grants, this group 
was analyzed. Pearson correlation of mentoring satisfaction vs. NIH grant funding showed 
positive correlation (r=0.333, p=0.025) in 2013 but a lack of any correlation (r= −0.05, 
p=0.327) in 2016. Applying this analysis to all members showed a similar pattern. Pearson 
correlation of mentoring satisfaction vs. total grant funding for all members showed positive 
correlation (r=0.225, p=0.001) in 2013 but lack of correlation (r= −0.036, p=0.349) in 2016.
US differed with international members on priority of potential research help. US members 
ranked seed grant and international members ranked receiving help in writing as the top 
useful help (Figure 7).
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Disincentives
Early career cardiologists suffered significant financial penalties when choosing an 
academic career (Figure 7). In 2013, 28% of the respondents gave up >$100,000/year to be 
in academics. This percentage has increased to 36% (11% internationals, 43% U.S.) in 2016. 
A greater percentage of international members (39%) do not incur any financial penalties for 
choosing academic cardiology than U.S. members (25%). The vast majority of US members 
(85%) are under a RVU system to receive credit for their clinical work, with 61% of these 
members reporting no credit for non-clinical endeavors. In contrast, only 27% of 
international members reported participation in a clinical revenue type of system. Similar 
percentages (13–14%) of international and US members reported high likelihood of leaving 
academics in the next 12 months. This is a slight increase from 11% in 2013. US members 
reported personal compensation being too low, and international members reported 
insufficient support for career development as the top reasons for leaving academic careers 
(Online Table 3).
DISCUSSION
Globally, the status of early career academic cardiologists has declined slightly since 2013; 
however, there were a number of positive developments as well. Negative items included: a 
global reduction in gaining funding for research has likely occurred (Figure 2, Online Tables 
1 and 2); only a minority of respondents reported satisfaction in teaching development 
(Figure 5); the ability of mentoring to positively affect grant outcome has diminished (Figure 
6); financial disincentives for pursuing academics is increasing (Figure 7); and 14% of early 
career members now reported high likelihood of leaving academics. In US, these results are 
consistent with a declining physician-scientist workforce as documented by NIH (6). 
Positive developments included: NHBLI has increased funding significantly through 
multiple mechanisms; ACC has provided new grants; and albeit currently small in numbers, 
ACC early career academic members continued to obtain NHLBI K-grants (Figure 3). In 
summation, continued attention needs to be directed towards the development of early career 
academic cardiologists.
Mentoring needs attention. A local mentor who can provide support, feedback, and when 
necessary hard-hitting critique, is pivotal importance in launching a physician-scientist’s 
career. All early career cardiologists need someone to whom “dumb questions” can be 
asked, someone who edits papers and grants with a fierce red pen, and someone who works 
through talks slide by slide. NIH has recognized the importance of the mentor; consequently, 
NIH formally evaluates the quality of applicants’ mentors in determining who will receive 
K-grants (11–13). Mentoring positively correlated with increasing grant funding in 2013 but 
not in 2016 while all other positive factors remain unchanged (Table 4, Figure 6). Together 
with ECACs’ inability to capitalize on NHBLI significantly increasing K-grant funding that 
specifically targets physician-scientists, mentoring appears to have lost its effectiveness. This 
can be caused by lost of effective mentors or mentoring ceasing to play a role. Regardless, 
restoring effective mentoring is crucial.
Different mentoring needs exist. NIH K-grant requirements include active R01 level 
funding, record of successful mentees, ability to support mentees’ research, actively 
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publishing, and being the expert in the field (11–13). Early career members will also need 
guidance in career development, negotiating a faculty position, and negotiating institutional 
support. Conversely, those who desire to mentor also need helpful development. Mentoring 
does not happen spontaneously. Rather, a matchmaking process needs to occur and a 
beneficial relationship needs to develop. Currently, both mentoring needs and mentor 
development needs remain relatively unknown. Perhaps, the first step to restore effective 
mentoring is to gain a better understanding of the needs. Subsequently, mentor support 
programs can be developed.
The mixed success of early career members achieving career development level funding 
support needs attention. Results showed diverging trends of decreasing percentage of US 
early career members receiving NIH K-grant level of funding (Figure-2E), despite 
significant NIH/NHLBI funding increases (Figure-2A–B). However, we identified many 
board certified cardiologists with NIH K-grants who are not ACC members. Determining 
why these individuals have chosen not to join the ACC is a topic that needs to be addressed. 
Conversely, a very small core of members is having some success (Figure 3). We need to 
find ways to extend the success of this small core to others who want to pursue academic 
cardiology. Broadening the opportunities for protected research time can expand success to 
others. Trainees and early career physician-scientists must achieve first authorship in an 
original research paper and expertise in their selected area in order to be competitive in grant 
application (11) An MD-PhD has a chance to accomplish this difficult task in 2 years.(6,11) 
An MD with less experience will likely need ≥3 years.(6,11) Unfortunately, the current 
Accreditation Council for Graduate Medical Education 3-year cardiovascular disease 
program does not allow time for the development of this competitive portfolio.(14) Thus, the 
protected time to complete research training has to occur in addition to a 3-year cardiology 
fellowship. Paid instructor level or new faculty positions with at least 75% protected 
research time support the development of competitive portfolios. In fact, K-grant awardees 
hold these positions at the time of K-grant application.(15) Programs with active NIH T32 
training grants, NIH Clinical Translational Science Awards (CTSAs), or institutional 
supported career development awards (Such as Vanderbilt’s Faculty Research Scholars 
Program) can provide these additional years of protected time. However, only a few centers 
currently provide these opportunties. Thus, we need to encourage interested institutions 
including private and community based healthcare systems to develop these early career 
faculty programs with protected research time outside of NIH funding to broaden 
opportunities.
This study also revealed that the transition from career development award (K-grant) to 
independent funding (R01 grant, which provides ≥ $1.25M) is a particularly vulnerable 
period. Early career members achieving >$1M grant support fell from 3% in 2013 to 1% in 
2016. These very small and decling percentages may reflect ACC members encountering 
significant challenges in making the transition to independent funding. On average, it takes 
K-grant recipients longer than 4 years and >3 R01 proposal attempts before obtaining a R01 
grant (15). K-grants require active practice licences; thus, physician-scientists are protected 
when competing for these grants. However, R01 grants have no such protection. With PhD-
only scientists who do not have clinical responsibilities being much more numerous (11), K-
grant recipients now face increased competition when applying for R01s. With the 
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combination of financial disincentives (43% took > $100,000/yr pay reduction) and the 
pressure to meet clinical RVU goals (52% do not receive RVU for academic pursuits), these 
forces can easily push US academic cardiologists to do more clinical work instead of 
spending efforts on experiments and writing grants. This shift towards clinical work can 
reduce both the quality and quantity of proposals being submitted. Developing funding 
streams that support physician-scientists and minimizing the financial disincentives may 
help. Developing suitable methods to provide credit for academic pursuits may also alleviate 
the pressure for clinical productivity.
International early career members have similar characteristics but additional needs. All 
members chose academic cardiology for similar reasons (Figure 1). All members believe 
that cardiologists should participate in healthcare research (Figure 5). International members 
need help with expanding institutional research infrastructure, including participation in 
international research collaborations, cardiovascular registries, and diversification of 
research funding streams.
Limitations
ACC membership limitation and 12% response rate may not sufficiently represent the entire 
ECAC population’s progression. Life priorities will change with each ECAC generation. 
This study does not provide anwers on why the funding of U.S. ECACs do not reflect the 
resources of their respective states. As a solution, we would like to suggest the creation of a 
registry to follow early career academic cardiologists starting from their last year in 
fellowship training to 10 years of practice. Involving program directors and cardiology 
chiefs can increase participation. This registry potentially will provide more accurate and 
timely information.
CONCLUSIONS
We believe that successful development of early career academic cardiologists is critical for 
continued viability of cardiology as a profession as well as advancing improved 
cardiovascular care globally. As illustrated by our study, even with some bright 
developments, global status of early career academic cardiology remain uncertain. Based on 
our analyses, we propose a set of potentially attainable solutions (Table 5) and call on the 
cardiovascular medicine community’s to help implement them.
ACC and Cardiovascular Professional Organizations
Professional societies provide guidance and leadership for both the profession and 
cardiovascular care. As illustrated by the uncertain status of early career academic 
cardiology, we urge the ACC and other socieities to continue evaluating the needs of the 
members, publishing the results, and implementing solutions. For now, restoring effective 
mentorship is a critical need. ACC has implemented new 1-year awards for early career 
members, and other societies also have provided early career support. We thank the ACC 
and other societies for these actions. However, as detailed earlier, 1-year duration is too short 
for an early career academic cardiogist to become competitive. Consequently, we urge 
expansion of the coverage to 2-years. Asking home institutions to provide matching funds 
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could provide a method for expansion to 2-years. With looming budget instability at the 
federal level and resulting hestation of institutions in supporting non revenue generating 
academic infrastructure, development of new philanthropic support dedicated to fund 
research and patient assistance in heart disease can help alleviate signficant funding needs.
Academic Medical Centers and Clinical Institutions
Actions of these entities determine the fate of early career cardiologists and their ability to 
pursuit academic interests. We believe that these entities hold the key to broaden the base to 
support successful development of early career academic cardiologists. Besides continuing 
to provide core capabilities and collegiate academic enviornment, we urge development of 
institutional programs to provide protected research time and find equitable methods to 
account for the value of academic pursuits.
Current and Future Academic Cardiologists
We believe that elucidating mechanisms and developing new treatments for CVD is an 
important cause with a global impact. However, one needs to understand the challenges, then 
make a strong commitment if persuit of this career is still desired. With commitment, one 
needs to choose wisely where to develop based on factors that have led to success. These 
factors (Table 4) consist of institutional resources (funding, core capabilities), institutional 
commitment to academic pursuits, availability of colloborators, and effective mentoring. 
Table 6 provides detailed recommendations, Online Table-4 provides current institutions 
with active NIH T-32 grants, and the site identifies active NIH CTSA locations. Our 
recommendations focus on resources not on clinical setting; therefore, one needs to look 
beyond university based academic centers for institutions (e.g., capable private/community 
based healthcare systems) that can provide the resources. It is important for us to function 
cohesively and persevere through the ebb and flow of funding environments. We must also 
recognize the importance of political advocacy and the role we must play in garnering 
attention towards research and academic pursuits in order to improve the current status. In 
conclusion, we wish you success, for there is great joy in not only practicing medicine but 
changing the way medicine is practiced.
CLINICAL COMPETENCIES
Identifying needs, proposing system solutions, and providing help to early career academic 
cardiologists addess the competencies of Professionalism, Practic-Based Learning, and 
System-Based Practice.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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CONDENSED ABSTRACT
The Early Career Section Academic Working Group of the American College of 
Cardiology (ACC) assessed the progress of early career academic cardiologists from 
2013–2016 using reported data and a membership-wide survey. The National Heart Lung 
and Blood Institute significantly increased funding of career development grants. 
However, only a small number of early career ACC members were able to benefit while 
funding of the entire cohort decreased. Mentoring lost its positive correlation with 
obtaining grants while personal motivation, institutional support, and collaborators 
continued to be positive influential factors. Analyses of this challenging situation led to 
recommendation of attainable solutions.
Tong et al. Page 13
J Am Coll Cardiol. Author manuscript; available in PMC 2018 October 31.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Early Career Academic Cardiologists’ Characteristics
(A) Sex and practice type distribution, (B) Motivation for pursuing academic cardiology, (C) 
Academic track and % research effort distribution, (D) Type of research.
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Figure 2. Funding Environment
(A) National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) 
funding of K-08 Mentored Clinical Scientist Development Award (Basic-Translation 
Research), (B) NIH/NHLBI funding of K-23 Mentored Patient-Oriented Research Career 
Development Award (Clinical Research), (C) American Heart Association (AHA) Fellow to 
Faculty transition award (three recipients declined the award in 2015 to depress the % for 
that year), (D) AHA Scientist Development Grant, (E) >$499K external funding for early 
career members with >40% research effort, (F) Funding distribution for all early career 
members for 2013 (only counted funding received as principal investigators (PIs)) and 2016 
(counted funding received as PI, Co-PI, and Co-investigator).
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Figure 3. K-Grant Awards for ACC Early Career Members
All fiscal year 2017 active NHLBI K-grants were extracted from NIH RePORTer. Principal 
investigators for these active K-grants were matched against ACC Membership database 
with ≤ 10 years from completing fellowship at the time of grant activation. The match 
showed number of ACC early career academic cardiologists successfully completing for K-
grant by year. Of note, some of the K-grant recipients have aged out of the early career range 
at the time of 2016 survey.
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Figure 4. Analyses by States of US
Fiscal year 2017 NIH research funding correlated with number of hospital beds (A) and 
number of teaching hospitals (B). Number of early career academic cardiologists (ECAC) 
correlated with number of hospital beds (C) and number of teaching hospitals (D). Average 
funding for ECACs with ≥ 40% research effort did not correlate with amount of NIH 
research funding received by state (E) and number of teaching hospitals by state (F). Data 
were extracted from NIH RePORTer,(16) Center for Medicare and Medicaid Services 
reporting of teaching hospitals,(17) and American Hospital Directory.(18)
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Figure 5. Challenges and Resources
Respondents provided rating for their beliefs and experiences pertaining to academic 
pursuits. Comparisons were done on US vs. international members on summation of the top 
two agreement responses.
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Figure 6. Focused Mentor Excellence to Grant Funding Analyses
Early career members’ reported onsite mentoring provides excellent guidance 1-strongly 
disagree to 5-strongly agree were plotted against external grant amount received. (A) 2013 
Total NIH funding for US members reporting > 40% of research effort, (B) 2016 Total NIH 
funding for US members reporting > 40% of research effort, (C) 2013 Total external funding 
for all members, (D) 2016 Total external funding for all members. Pearson correlation 
analyses were performed between members’ rating of mentoring to achieved grant support 
(correlation coefficient r and p values are listed within the figures).
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Figure 7. Penalties and Requested Help
(A) Members’ reported salary reductions for pursuing academic cardiology with respect to 
their peers, (B) Reported application of relative value units (RVU), (C) Likelihood of leaving 
academic cardiology in the next 12 months, (D) Top three areas where members believe 
ACC can best meet their research needs.
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Central Illustration. Early Career Academic Cardiologist
Personal motivation and commitment sustains drives the progress. Institutional support and 
mentoring help to deliver the external funding to sustain life. Successful actions provide 
scientific discoveries and deliver outstanding patient care.
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Table 1
Description of academic cardiology promotion tracks
Academic Tracks Roles, Efforts, Time Spent
(1) Scientist- researcher
• Dedicate nearly 100% effort to research.
• Serve as principal investigators in basic, translational and/or clinical research.
• Minimal or no clinical responsibilities.
• Funding comes primarily from peer-reviewed extramural or institutional grants.
• The emphasis is on investigation and discovery.
• The academic promotion is based on demonstration of scholarship (i.e., publications 
of original research, large multidisciplinary studies, and sustained record of 
extramural funding).
(2) Clinician-scientist or Physician-
scientist
• Provide direct patient care and conduct research as principal investigators (basic, 
translational, and/or clinical).
• Develop and test research hypotheses, have a research focus, contribute through 
publications and extramural funding.
• Strong teaching component, including didactic lectures and serving as the teaching 
attending for medical students, residents or fellows on clinical services.
• This track offers flexibility between commitment to research, education, and clinical 
care.
• The promotion is based on contributions to research, educational activities, and 
clinical expertise.
(3) Clinician-educator
• Dedicate a significant amount of time to educational activities.
• Educational activities include didactic teaching of students, residents, fellows and 
peers (lectures, seminars, tutorials, continuing medical education courses), 
mentoring and serving as advisor to trainees, clinical teaching and bedside 
preceptorship, in clinic and/or in procedural areas, commonly through an associated 
medical school and/or graduate medical education program.
• Serve as teachers and mentors for allied health professionals, such as physician 
assistants, nurse practitioners, and pharmacy students.
• The promotion is based on contributions to educational activities and trainees’ 
success
(4) Clinician-educator-administrator
• Have responsibilities in course administration, rotation administration, and clinical 
operations in addition to the role of clinician-educator.
• Educational leadership responsibilities, such as residency or fellowship director, 
medical school course or seminar director.
• Scholarly approach to educational leadership, developing educational materials 
(syllabi, curricula, training modules or courses), technologies (simulation), and 
educational assessment tools.
• Demonstrate leadership roles in institutional, regional and national education 
courses, committees, and publish original research related to educational methods.
(5) Pure clinician
• The primary role is providing direct patient care.
• Dedicate almost 100% of their efforts to direct patient care, and teaching is 
performed primarily in the course of clinical duties.
• Typically, this group does not have protected time for research or educational 
activities, and those who wish to pursue those activities, may have to do so outside 
of their allotted clinical time and defined duties.
• Academic promotion commonly requires some demonstration of scholarship, 
leadership or teaching in addition to clinical excellence.
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Table-2
Distribution of Roles
Professional Role 2013 Survey, n=291 2016 Survey, n=841
100% research 0.7% 0.7%
>75% research 5.8% 4.6%
40–75% research 10.0% 9.3%
<40% research 28.5% 25.9%
Clinician-Educator 18.6% 18.5%
Clinician-Educator-Administrator 11.3% 7.3%
Pure Clinicians* 25.1% 33.7%
*
Indicates early exit from survey; therefore, not included in follow-on analyses.
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Table-3
Funding Sources and Barriers Among Selected International Sites
Country Primary Mode of Funding for Cardiovascular Research Country-Specific Examples of Funding Streams
Canada Non-Commercial Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada
Germany Non-Commercial
German Centre for Cardiovascular Research (Deutsches Zentrum für 
Herz-Kreislauf-Forschung, DZHK); German Research Foundation 
(Deutsche Forschungsgemeinschaft, DFG);German Cardiac Society 
(Deutsche Gesellschaft für Kardiologie – Herz- und 
Kreislaufforschung, DGK)
India Commercial and Non-commercial Indian council of Medical Research; Public health Foundation of India (PHFI); All India Institute of Medical Sciences (AIIMS)
Israel Non-commercial Israel Science Foundation; Israel Heart Society
Mexico Non-commercial National Council of Science and Technology; Carlos Slim Institute of Health; Mexican Education Ministry
Turkey Non-commercial Scientific and Technological Research Council of Turkey (TUBITAK)
United Kingdom Commercial and Non-commercial British Heart Foundation; Association of Medical Research Charities (AMRC); National Institute for Health Research (NIHR)
Barriers to Successful Academic Career:
Insufficient research infrastructure at home institution
Lack of access to cardiovascular registries and transnational research collaborations
Insufficient bridge/pilot funding at home institution
Limited research funding streams with limited research funding amounts
Non-commercial: Foundations, charities, government departments, research institutes Commercial: Medical industry, for-profit companies
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Table-4
Factors that correlated with increasing amount of external grant funding
Factor US NIH
Total
2013
US NIH
Total
2016
All
Total
2013
All
Total
2016
[Motivation] Physicians need to lead or be a part of healthcare research +↑ +↑ +↑ +↑
[Home Institution] My home institution provides me with sufficient bridge funding/intermediary 
support to launch my career.
+↑ +↑ — +↑
[Home Institution] My home institution possesses sufficient resources (e.g. core facilities, expertise, 
databases…) to support my research.
+↑ +↑ +↑ +↑
[Collaborators] Necessary connections to collaborators are readily available. +↑ +↑ +↑ +↑
[Mentoring] Onsite mentoring provides excellent guidance. +↑ — +↑ —
[Home Institution] My home institution values my academic pursuits. +↑ +↑ +↑ +↑
[Experience] Funding in support of academic endeavors has been unstable with external grants 
and/or internal institutional support.
— +↑ — +↑
[Experience] Complying with regulatory bodies is burdensome. — +↑ — +↑
Spearman Correlation was done between responses to challenges-resources factors (responses:1–5; 1:strongly disagree; 5:strongly agree) vs. 
obtained total grant amount by ranges (0, $1–99K, $100K-249K, $250–499K, ≥$500K).
+↑ denotes positive correlation with p<0.05.
— denotes no correlation. Mentoring changed from being a positive correlation factor for US members to obtain NIH grants to be non-
contributory (2013: r=0.236, p=0.001; 2016: r=0.081, p=0.103). Mentoring changed from being a positive correlation factor for all members for all 
grants to be non-contributory (2013: r=0.241, p=0.001; 2016: r=0.070, p=0.115).
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Table-5
Recommendations
Recommendations to ACC and Cardiovascular Professional Organizations
✥ Continue to conduct studies on its members and publish results on regular basis (e.g., every 3 years)
✥ Develop a registry that will follow a representative cohort of early career academic cardiologists in their progression over time (starting from 
last year of fellowship and follow for 10 years after completion of fellowship)
✥ Conduct follow-on studies to fill in knowledge gaps
 ➢ Mentoring needs (career development, becoming NIH funded principal investigator, contract negotiations)
 ➢ Needs of the mentors (this can be critical to foster collegiate inter-generational communications and to ensure a base level of mentoring 
skills)
 ➢ Early career members’ commitment and its associated needs (e.g. committed to academic cardiology, want to explore possibilities, 
committed to clinical care)
✥ Promote mentoring
 ➢ Provide mentoring workshops after identification of mentoring and mentors’ needs
 ➢ Provide increased recognition beyond one award per year (e.g., by category: basic/translation/clinical, by stage: early-first 5 years of 
mentoring experience, middle-mentored from 5–15 years, senior-mentored for >15 years and has a record of mentees achieving independent 
faculty positions)
 ➢ Upgrade existing mentoring database
✥ Modify current early career junior faculty 1-year awards to cover at least 2 years
 ➢ Require home institution to guarantee >50% research effort
 ➢ As a possible no cost expanding method, funding one $70,000/yr for 2-year duration instead of two $70,000/yr grants for 1-year.
 ➢ Consider seeking additional industry, philanthropy, and membership donation to fund this program
 ➢ Consider expanding this program in the future after learning from results and establishing fund
✥ Help to establish heart disease philanthropic foundation that will fund research and assist patients. (Susan G. Komen is a good example from 
breast cancer: their mission statement - “Save lives by meeting the most critical needs in our communities and investing in breakthrough 
research to prevent and cure breast cancer”). Unlike ACC and AHA, this foundation needs to be free from lobbying to maintain tax exemption 
and good will of contributing public. Better Business Bureau Wise Giving Alliance reported total program expenses for 2015: American Cancer 
Society $708,516,000; Susan G. Komen Foundation $217, 779,902; AHA $527,297,000. These numbers suggest that heart disease based 
foundation in addition to AHA is possible and needed.
✥ Advocate for increased funding for NHLBI in T-32 training grants, career development grants, and research grant targeting early career 
physician-scientists
✥ Develop workshop and exchange program to help international members in writing
✥ Develop requirement statement for advanced cardiovascular research training (e.g. Level – II and Level-III) for the next iteration of ACC 
curriculum recommendation document COCATS
 ➢ Writing team needs to include recent K-08, K-23, and R-01 recipients
 ➢ NHBLI input will also be useful
Recommendation to Academic Centers and Clinical Institutions
✥ Continue to compete for federal funding that support protected research time (i.e., T-32, CTSA)
✥ Develop funding mechanisms outside of federal grant that can fund protected research time at >75% effort during the fellowship years for >2 
years
✥ Develop partnership with land-grant universities (e.g., tenure track professor positions) to provide funding for salary to support protected 
research time of faculty academic cardiologists outside of clinical revenue stream (example: Baylor Scott & White - Texas A&M University)
✥ Develop partnership with philanthropic foundation to provide funding for salary to support protected research time of faculty academic 
cardiologists outside of clinical revenue stream (example: Vanderbilt University Medical Center Faculty Research Scholars Program)
✥ Developed methods to provide credit for academic pursuits such research and teaching. The credit can be in non-monetary form such as 
valued components for promotion.
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Table-6
Factors for Choosing an Institution
What to look for in a Fellowship Program What to look for in a Cardiologist Position that can 
support academic pursuits
✥ Institutional Resources
➢NIH CTSA (https://ncats.nih.gov/ctsa)
➢NIH T-32 Grant (https://projectreporter.nih.gov/reporter.cfm; 
Grant Type:T32; center: HL)
➢Non-federal mechanisms to fund protected research time for 
fellows > 2 years
➢Protected research time (> 75% research for > 2 years) to produce 
first author paper and transferrable reagents/models to apply for 
grant (2 years is the minimum, non MD-PhD will likely need 3+ 
years)
➢One may need to tradeoff clinical skill vs. research time if one 
wants to complete the clinical portion in 24 months
✥ Mentors who can meet NIH K-grant qualifications (recognized expert in 
the field, active R01 grant or equivalent, actively publishing, track 
record of mentees successfully transitioning to positions of independent 
principal investigator)
✥ Core facilities and ongoing research in the area of interest
✥ Track record of fellows transitioning to faculty positions that supported 
independent investigation
✥ Institutional Resources
➢Startup Fund to run research without external 
support for > 3 years (>$750,000; not 
including salary support for yourself)
➢Protected research time and compensation if 
promised protected research time is 
interrupted (i.e., increased funding and 
technical support)
➢CTSA and Institutional KL2
➢Core facilities that can directly support your 
research
✥ Mentoring
➢Mentors who meets NIH K-grant 
qualifications and will truly invest in you
➢Mentorship program (e.g., career 
development, proposal preparation, 
promotion)
✥ Collaboration
➢Existence of potential collaborators
➢Culture of collaboration (need to find junior 
faculty member(s) who will speak to you 
honestly)
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